IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Walpar Nutritions IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Gandhinagar and caters to Healthcare - Ayurvedic sector. Beeline Capital Advisors is the merchant banker of Walpar Nutritions IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 15th June 2021.
Walpar Nutritions IPO posted revenues of ₹ 16.71 crores and PAT of ₹ 0.12 crores in FY21 on annualised basis.
Revenue:
₹ 1.43 Cr.
EBITDA Margin:
25.87
% 
Net Worth: ₹ 3.23 Cr.
Market Capitalisation:
₹ 7.68 Cr.
P/E:
64.00 times
P/BV: 0.78 times
EV/EBITDA: 32.32 times
Financial results of Walpar Nutritions IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Dec-20 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 4.54 | 13.17 | 9.18 | 3.90 | |
| Net Worth | 3.23 | 1.93 | 1.08 | 0.78 | |
| Total Debt | 4.73 | 4.73 | 3.66 | 1.37 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
1.43
1.43 |
16.71 | 12.82 | 6.45 | |
EBITDA
EBITDA on annualised basis |
0.37
0.37 |
1.21 | 0.80 | 0.41 | |
PAT
PAT on annualised basis |
0.23
0.23 |
0.12 | 0.07 | [●] | |
Walpar Nutritions IPO PAT Margin is 16.08 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Walpar Nutritions IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Dec-20 | FY20 | FY19 | FY18 |
|---|---|---|---|---|
| EBITDA Margin (%) | 25.87 | 7.24 | 6.24 | 6.36 |
| PAT Margin (%) | 16.08 | 0.72 | 0.55 | [●] |
| EPS (₹) | 0.76 | 0.41 | 0.23 | 0.01 |
| ROE (%) | 7.12 | 6.22 | 6.48 | [●] |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 5.07 | 0.91 | 0.76 | [●] |
| Debt to Equity | 1.46 | 2.45 | 3.39 | 1.76 |
The market Capitalisation of Walpar Nutritions IPO is ₹ 7.68 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Walpar Nutritions IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Walpar Nutritions IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Walpar Nutritions IPO is ₹ 7.68 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Walpar Nutritions IPO has a Price-to-Earnings (PE) ratio of 64.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Walpar Nutritions IPO reported revenue of ₹ 16.71 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Walpar Nutritions IPO provide insights into sales growth, market demand, and business scalability.
Walpar Nutritions recorded an EBITDA of ₹ 0.37 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Walpar Nutritions Profit After Tax (PAT) is ₹ 0.23 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 1.43 Cr.
EBITDA Margin:
25.87
%
Net Worth: ₹ 3.23 Cr.
Market Capitalisation:
₹ 7.68 Cr.
P/E:
64.00 times
P/BV: 0.78 times
EV/EBITDA: 32.32 times
Walpar Nutritions operates in Healthcare - Ayurvedic and Manufacturing Of Utraceutical, Ayurvedic, Cosmeceuticals Products. The Issue is listed on NSE EMERGE in Jul, 2021. Walpar Nutritions IPO size was 6.60 with Issue price of 55.00 .
Merchant Banker(s) of Walpar Nutritions IPO: Beeline Capital Advisors Private Limited
Walpar Nutritions IPO subscription was 9.48 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Walpar Nutritions IPO listed at a listing price of 59.95 against the offer price of 55.00.
The current market price of Walpar Nutritions is 46.00.
Why Us?
